Cargando…

Natural course of pontocerebellar hypoplasia type 2A

INTRODUCTION: Pontocerebellar hypoplasia Type 2 (PCH2) is a rare autosomal recessive condition, defined on MRI by a small cerebellum and ventral pons. Clinical features are severe developmental delay, microcephaly and dyskinesia.Ninety percent carry a p.A307S mutation in the TSEN54-gene. Our aim was...

Descripción completa

Detalles Bibliográficos
Autores principales: Sánchez-Albisua, Iciar, Frölich, Saskia, Barth, Peter G, Steinlin, Maja, Krägeloh-Mann, Ingeborg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4019562/
https://www.ncbi.nlm.nih.gov/pubmed/24886362
http://dx.doi.org/10.1186/1750-1172-9-70
_version_ 1782480186567032832
author Sánchez-Albisua, Iciar
Frölich, Saskia
Barth, Peter G
Steinlin, Maja
Krägeloh-Mann, Ingeborg
author_facet Sánchez-Albisua, Iciar
Frölich, Saskia
Barth, Peter G
Steinlin, Maja
Krägeloh-Mann, Ingeborg
author_sort Sánchez-Albisua, Iciar
collection PubMed
description INTRODUCTION: Pontocerebellar hypoplasia Type 2 (PCH2) is a rare autosomal recessive condition, defined on MRI by a small cerebellum and ventral pons. Clinical features are severe developmental delay, microcephaly and dyskinesia.Ninety percent carry a p.A307S mutation in the TSEN54-gene. Our aim was to describe the natural course including neurological and developmental features and other aspects of care in a homogeneous group of PCH2 patients all carrying the p.A307S mutation. PATIENTS AND METHODS: Patients were recruited via the German patients' organizations. Inclusion criteria were imaging findings of PCH2 and a p.A307S mutation. Data were collected using medical reports and patient questionnaires discussed in a standardized telephone interview. RESULTS: Thirty-three patients were included. When considering survival until age 11 years, 53% of children had died Weight, length and head circumference, mostly in the normal range at birth, became abnormal, especially head circumference (-5.58 SD at age 5 yrs). Neurologic symptoms: Choreathetosis was present in 88% (62% with pyramidal signs), 12% had pure spasticity. Epileptic seizures were manifest in 82%, status epilepticus in 39%. Non-epileptic dystonic attacks occurred in 33%. General symptoms: feeding difficulties were recorded in 100%, sleep disorder in 96%, apneas in 67% and recurrent infections in 52%; gastroesophageal reflux disease was diagnosed in 73%, 67% got percutaneous endoscopic gastrostomy and 36% a Nissen-fundoplication. Neurodevelopmental data: All children made progress, but on a low level: such as fixing and following with the eyes was seen in 76%, attempting to grasp objects (76%), moderate head control (73%), social smile (70%), rolling from prone to supine (58%), and sitting without support (9%). Ten percent lost achieved abilities on follow-up. The presence of prenatal symptoms did not correlate with outcome. CONCLUSION: Phenotype of this genetically homogeneous group of PCH2 children was severe with reduced survival, but compatible with some developmental progress. Our data support the hypothesis of an early onset degeneration which thereafter stabilizes.
format Online
Article
Text
id pubmed-4019562
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-40195622014-05-14 Natural course of pontocerebellar hypoplasia type 2A Sánchez-Albisua, Iciar Frölich, Saskia Barth, Peter G Steinlin, Maja Krägeloh-Mann, Ingeborg Orphanet J Rare Dis Research INTRODUCTION: Pontocerebellar hypoplasia Type 2 (PCH2) is a rare autosomal recessive condition, defined on MRI by a small cerebellum and ventral pons. Clinical features are severe developmental delay, microcephaly and dyskinesia.Ninety percent carry a p.A307S mutation in the TSEN54-gene. Our aim was to describe the natural course including neurological and developmental features and other aspects of care in a homogeneous group of PCH2 patients all carrying the p.A307S mutation. PATIENTS AND METHODS: Patients were recruited via the German patients' organizations. Inclusion criteria were imaging findings of PCH2 and a p.A307S mutation. Data were collected using medical reports and patient questionnaires discussed in a standardized telephone interview. RESULTS: Thirty-three patients were included. When considering survival until age 11 years, 53% of children had died Weight, length and head circumference, mostly in the normal range at birth, became abnormal, especially head circumference (-5.58 SD at age 5 yrs). Neurologic symptoms: Choreathetosis was present in 88% (62% with pyramidal signs), 12% had pure spasticity. Epileptic seizures were manifest in 82%, status epilepticus in 39%. Non-epileptic dystonic attacks occurred in 33%. General symptoms: feeding difficulties were recorded in 100%, sleep disorder in 96%, apneas in 67% and recurrent infections in 52%; gastroesophageal reflux disease was diagnosed in 73%, 67% got percutaneous endoscopic gastrostomy and 36% a Nissen-fundoplication. Neurodevelopmental data: All children made progress, but on a low level: such as fixing and following with the eyes was seen in 76%, attempting to grasp objects (76%), moderate head control (73%), social smile (70%), rolling from prone to supine (58%), and sitting without support (9%). Ten percent lost achieved abilities on follow-up. The presence of prenatal symptoms did not correlate with outcome. CONCLUSION: Phenotype of this genetically homogeneous group of PCH2 children was severe with reduced survival, but compatible with some developmental progress. Our data support the hypothesis of an early onset degeneration which thereafter stabilizes. BioMed Central 2014-05-05 /pmc/articles/PMC4019562/ /pubmed/24886362 http://dx.doi.org/10.1186/1750-1172-9-70 Text en Copyright © 2014 Sánchez-Albisua et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Sánchez-Albisua, Iciar
Frölich, Saskia
Barth, Peter G
Steinlin, Maja
Krägeloh-Mann, Ingeborg
Natural course of pontocerebellar hypoplasia type 2A
title Natural course of pontocerebellar hypoplasia type 2A
title_full Natural course of pontocerebellar hypoplasia type 2A
title_fullStr Natural course of pontocerebellar hypoplasia type 2A
title_full_unstemmed Natural course of pontocerebellar hypoplasia type 2A
title_short Natural course of pontocerebellar hypoplasia type 2A
title_sort natural course of pontocerebellar hypoplasia type 2a
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4019562/
https://www.ncbi.nlm.nih.gov/pubmed/24886362
http://dx.doi.org/10.1186/1750-1172-9-70
work_keys_str_mv AT sanchezalbisuaiciar naturalcourseofpontocerebellarhypoplasiatype2a
AT frolichsaskia naturalcourseofpontocerebellarhypoplasiatype2a
AT barthpeterg naturalcourseofpontocerebellarhypoplasiatype2a
AT steinlinmaja naturalcourseofpontocerebellarhypoplasiatype2a
AT kragelohmanningeborg naturalcourseofpontocerebellarhypoplasiatype2a